(1)
Keller, MD, PhD, G. A.; Villa Etchegoyen, MD, C.; Fernandez, PharmD, PhD, N.; Olivera, PharmD, PhD, N. M.; Quiroga, PharmD, PhD, P. N.; Diez, PhD, R. A.; Di Girolamo, MD, PhD, G. Dextropropoxyphene Effects on QTc-Interval Prolongation: Frequency and Characteristics in Relation to Plasma Levels. J of Opioid Management 2018, 14, 335-344.